Trevi Therapeutics - 53 Year Dividend History | TRVI

Historical dividend payout and yield for Trevi Therapeutics (TRVI) since 1971. The current TTM dividend payout for Trevi Therapeutics (TRVI) as of July 19, 2024 is $0.00. The current dividend yield for Trevi Therapeutics as of July 19, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.196B $0.000B
Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. The company is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis and levodopa-induced dyskinesia in patients with Parkinson's disease. Trevi Therapeutics Inc. is based in New Haven, Connecticut.
Stock Name Country Market Cap PE Ratio